Diabetes drug metformin found to reduce cancer risk
LOS ANGELES — A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers say.
A study in mice exposed to tobacco carcinogens, published Sept. 1, shows that the drug can reduce the development of lung tumors by as much as 70 percent, and results from a small clinical trial in Japan suggest it can reduce rates of colorectal tumors in humans. The Nat...
You have selected to view an article that is older than 60 days. There are several ways to unlock access to NewsOK historical content.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
